Chekkit
Lagos, NG Β· Founded 2018 Β· 22 employees on LinkedIn Β· 8 known investors
Chekkit provides product authentication and distribution tracking technology, offering labels that verify product genuineness for manufacturers and producers of consumer goods and pharmaceutical products. The company works with small, medium, and large enterprises, with a particular focus on Africa.
Also known as Chekkit Technologies Β· Chekkit Technologies Corp.
Investors Β· 8
Also in the syndicate Β· 6
Company profile
researched Aug 2026Chekkit Technologies Corp. is a product verification and anti-counterfeiting technology company founded in 2018 and incorporated in Nigeria and the USA. Its platform lets consumers confirm that packaged medicines, food, beverages, cosmetics and other consumer goods are genuine, while giving manufacturers a direct channel to those consumers. Verification is performed through the ChekkitApp mobile application or by dialling a USSD shortcode against GS1-standard serial codes printed on product packaging.
The product suite comprises ChekkitApp (consumer verification with instant rewards), ChekIntel (first-party consumer data and market insight for brands), ChekTrace (serialization aligned with GS1 and NAFDAC/FDA guidelines, described as compliant in over 100 countries and implementable without new production-line equipment) and ChekTrack (consumer verification plus collection of insights on side effects, drug efficacy, purchase patterns and sales locations). Related solutions cover consumer loyalty, retailer loyalty, supply chain track-and-trace and real-time asset tracking for logistics and storage. The company describes its stack as blockchain-powered, using a distributed ledger to secure the unique identifiers it generates or ingests from ERP partners, preventing duplication of serial codes and protecting consumer personal data.
Customers and counterparties named by the company include pharmaceutical firms Merck, Royal Star Pharma and Nabros Pharmaceutical, and consumer brands Indomie, Nivea and Flour Mills of Nigeria Plc. Chekkit has also worked with regulatory and standards bodies including NAFDAC, GS1 and the FCCPC, and deployed a COVID-19 engagement solution with the African Union and Africa CDC.
Founding story
Chekkit Technologies Corp. was founded in 2018 by Dare Odumade, supported by co-founders Oluwatosin Adelowo and Samuel Ukhueleigbe, to offer product verification and anti-counterfeiting technology and give manufacturers a way to engage consumers directly.
Business model
Chekkit sells authentication, serialization, traceability and consumer-intelligence software to manufacturers, importers, distributors, retailers, NGOs and regulators, including a traceability and consumer-intelligence SaaS offering listed on the SAP store and integrated with SAP Advanced Track and Trace for Pharmaceuticals. Serialized GS1 codes applied to packaging are scanned by end consumers, generating verification events and survey data that are returned to the brand.
Software-as-a-service for consumer brands covering end-to-end loyalty campaigns, engagement-data aggregation and reward distribution, alongside serialization and traceability software for manufacturers.
Traction
The company states that over 100 million medicine, food, beverage and cosmetics products have been certified through its platform. At the time of its 2023 funding announcement it reported having helped secure over 50 million pharmaceutical and consumer goods products; at the 2021 pre-seed announcement it reported over 7 million pharmaceutical products secured, more than 200,000 consumers protected, and an expanded partnership with the Afghan government covering verification and tracking of over 200 million products.
Latest developments
In April 2023 Chekkit announced additional funding from Adaverse, a Cardano ecosystem accelerator, with participation from existing investors RTA, HoaQ, Launch Africa and Blockchain Founders Fund, to be used for scaling the team, technology and product distribution and for launching in India and the UK. The raise followed the company's announcement as the first approved GS1/NAFDAC traceability solutions provider in Nigeria, ahead of NAFDAC serialization rules taking effect from the end of 2024.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Chekkit states it was announced as the first approved GS1/NAFDAC traceability solutions provider in Nigeria and targets becoming the leading traceability platform in Africa, positioning itself ahead of a NAFDAC mandate for end-to-end pharmaceutical serialization and traceability taking effect from the end of 2024.
The company combines anti-counterfeiting serialization with first-party consumer intelligence, claiming its labels drive substantially more consumer verifications than other mobile authentication service labels and enabling brands using SAP's track-and-trace platform to collect last-mile patient data through surveys embedded in GS1 serial codes. It also emphasises serialization compliance without significant new production equipment.
Technology
Blockchain/distributed-ledger infrastructure secures unique product identifiers generated by Chekkit or ingested from ERP partners, guarding against serial-code duplication and protecting consumer data. The platform implements GS1 global standards and NAFDAC/FDA serialization guidelines, supports post-production as well as in-line serialization, and exposes verification via QR codes, a mobile app and USSD shortcodes. Management has stated an intention to release an open-source web3 API for third-party developers building on product data.
Go-to-market
Direct sales to manufacturers and importers supported by demo requests, partnerships with regulators and standards bodies (NAFDAC, GS1, FCCPC), distribution through the SAP store and integration with SAP Advanced Track and Trace, and content marketing via a blog and webinars on serialization and traceability.
Pharmaceutical manufacturers, FMCG and consumer packaged goods producers, wines and spirits, cosmetics and electronics/equipment brands, plus importers, distributors, retailers, NGOs, government bodies and regulators; the company states experience with small, medium and FTSE 100 companies.
Geography
Headquartered in Ikoyi, Lagos, Nigeria, with listed addresses in Houston, Texas (USA) and London, UK, and incorporation in Nigeria and the USA. Deployments have covered Nigeria and Afghanistan, with stated expansion plans into India, the UK and the Middle East.
History
Founded in 2018 by Dare Odumade with Oluwatosin Adelowo and Samuel Ukhueleigbe as co-founders. It ran a drug verification pilot in Afghanistan that went national in 2021, closed a $500,000 pre-seed round in 2021, appointed a Pharmaceutical Marketing Association president as non-executive director in November 2022, listed its traceability and consumer-intelligence SaaS on the SAP store in September 2022, and in April 2023 announced an additional undisclosed round led by Adaverse.
Risks & controversies
The business is exposed to the timing and enforcement of NAFDAC's pharmaceutical serialization and traceability regulation, which the company says takes effect from the end of 2024, and to execution risk in entering new markets in India, the UK and the Middle East.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 7
launches, deals, and filingsChekkit raised an undisclosed round from Adaverse, a Cardano ecosystem accelerator, with participation from existing investors RTA, HoaQ, Launch Africa and Blockchain Founders Fund, to scale its blockchain-powered drug safety and tracking technology and expand into India and the UK.
Chekkit's traceability and consumer intelligence SaaS became available on the SAP store, integrating with SAP's Advanced Track and Trace for Pharmaceuticals.
Chekkit announced a $500,000 pre-seed round with Launch Africa, Japan Strategic Capital, Blockchain Founders Fund, two angel syndicate groups and a grant from the Orange Corners program; angel syndicate co-leader Biola Alabi joined the advisory board.
$500K source β
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Chekkitchekkitapp.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Chekkit do?
- Nigerian company providing blockchain-based product authentication, serialization and consumer-intelligence tools for pharma and FMCG brands.
- Who are Chekkit's investors?
- Chekkit's investors include Adaverse, Co-Creation Hub (CcHUB).
- Where is Chekkit headquartered?
- Chekkit is headquartered in Lagos, NG.
